J&J beats Wall Street quarterly sales & profit estimates
Johnson & Johnson today reported first-quarter revenue and profit above Wall Street estimates, driven again by strong sales of its cancer treatments including multiple myeloma medicine Darzalex.
Business
• 15 Apr
